Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1954 1
1955 2
1958 1
1959 1
1961 1
1963 2
1964 5
1965 5
1966 4
1967 5
1968 15
1969 7
1970 20
1971 15
1972 5
1973 7
1974 9
1975 12
1976 18
1977 18
1978 19
1979 19
1980 20
1981 22
1982 18
1983 22
1984 25
1985 38
1986 18
1987 18
1988 38
1989 34
1990 28
1991 25
1992 23
1993 23
1994 29
1995 22
1996 45
1997 54
1998 26
1999 21
2000 42
2001 17
2002 26
2003 20
2004 15
2005 12
2006 12
2007 7
2008 9
2009 11
2010 11
2011 10
2012 5
2013 5
2015 7
2016 6
2017 6
2018 10
2019 7
2020 9
2021 5
2022 10
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

1,004 results

Results by year

Filters applied: . Clear all
Page 1
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Galsky MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, Chan KG, Lewis S, Achkar BE, Dorff TB, Cetnar JP, Neil BO, D'Souza A, Mamtani R, Kyriakopoulos C, Jun T, Gogerly-Moragoda M, Brody R, Xie H, Nie K, Kelly G, Horowitz A, Kinoshita Y, Ellis E, Nose Y, Ioannou G, Cabal R, Del Valle DM, Haines GK, Wang L, Mouw KW, Samstein RM, Mehrazin R, Bhardwaj N, Yu M, Zhao Q, Kim-Schulze S, Sebra R, Zhu J, Gnjatic S, Sfakianos J, Pal SK. Galsky MD, et al. Among authors: nose y. Nat Med. 2023 Nov;29(11):2825-2834. doi: 10.1038/s41591-023-02568-1. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783966 Free PMC article. Clinical Trial.
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.
Nose Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kawashima A, Haruna M, Hirata M, Ueyama A, Iwahori K, Satoh T, Kurokawa Y, Eguchi H, Doki Y, Wada H. Nose Y, et al. Cancer Immunol Immunother. 2023 Jan;72(1):169-181. doi: 10.1007/s00262-022-03240-2. Epub 2022 Jul 1. Cancer Immunol Immunother. 2023. PMID: 35776160
Tele-VAD.
Nosé Y. Nosé Y. Artif Organs. 1997 Oct;21(10):1055. doi: 10.1111/j.1525-1594.1997.tb00441.x. Artif Organs. 1997. PMID: 9335360 No abstract available.
Artificial endocrine pancreas.
Hanazaki K, Nosé Y, Brunicardi FC. Hanazaki K, et al. Among authors: nose y. J Am Coll Surg. 2001 Sep;193(3):310-22. doi: 10.1016/s1072-7515(01)01014-6. J Am Coll Surg. 2001. PMID: 11548802 No abstract available.
Biocompatibility: bioengineering aspects.
Murabayashi S, Nose Y. Murabayashi S, et al. Among authors: nose y. Biomed Mater Eng. 2013;23(1-2):129-42. doi: 10.3233/BME-120738. Biomed Mater Eng. 2013. PMID: 23442243
From Appalachia to the world.
Nosé Y. Nosé Y. Artif Organs. 2009 Sep;33(9):674-8. doi: 10.1111/j.1525-1594.2009.00904.x. Artif Organs. 2009. PMID: 19775257 No abstract available.
Hyperbaric oxygenation: is it an hepatic assist device?
Mizuguchi K, Nosé Y. Mizuguchi K, et al. Among authors: nose y. Artif Organs. 1994 Aug;18(8):545-6. doi: 10.1111/j.1525-1594.1994.tb03376.x. Artif Organs. 1994. PMID: 7993188 No abstract available.
Perioperative Ghrelin Administration Attenuates Postoperative Skeletal Muscle Loss in Patients Undergoing Esophagectomy for Esophageal Cancer: Secondary Analysis of a Randomized Controlled Trial.
Nose Y, Yamashita K, Takeoka T, Momose K, Saito T, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Shiraishi O, Miyata H, Yasuda T, Yano M, Eguchi H, Doki Y. Nose Y, et al. Ann Surg Oncol. 2022 Jun;29(6):3604-3612. doi: 10.1245/s10434-022-11436-0. Epub 2022 Feb 20. Ann Surg Oncol. 2022. PMID: 35187621 Clinical Trial.
1,004 results